Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ovarian Neoplasms | 8 | 2024 | 581 | 1.610 |
Why?
|
| Wnt Signaling Pathway | 2 | 2020 | 202 | 0.600 |
Why?
|
| Endometrial Neoplasms | 1 | 2020 | 196 | 0.550 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2020 | 268 | 0.510 |
Why?
|
| Poly(ADP-ribose) Polymerase Inhibitors | 4 | 2023 | 134 | 0.480 |
Why?
|
| Cystadenocarcinoma, Serous | 3 | 2022 | 83 | 0.470 |
Why?
|
| Antineoplastic Agents | 2 | 2023 | 2162 | 0.420 |
Why?
|
| Drug Resistance, Neoplasm | 4 | 2023 | 840 | 0.380 |
Why?
|
| Phthalazines | 3 | 2023 | 63 | 0.340 |
Why?
|
| Piperazines | 3 | 2023 | 375 | 0.300 |
Why?
|
| Hedgehog Proteins | 2 | 2022 | 200 | 0.290 |
Why?
|
| Cell Line, Tumor | 5 | 2023 | 3502 | 0.210 |
Why?
|
| Activating Transcription Factor 6 | 1 | 2023 | 20 | 0.200 |
Why?
|
| Transcription Factor AP-1 | 1 | 2023 | 86 | 0.190 |
Why?
|
| Semaphorins | 1 | 2022 | 35 | 0.180 |
Why?
|
| Epoxy Compounds | 1 | 2020 | 31 | 0.160 |
Why?
|
| Carnitine O-Palmitoyltransferase | 1 | 2020 | 48 | 0.160 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2020 | 1439 | 0.150 |
Why?
|
| Genomics | 1 | 2024 | 811 | 0.150 |
Why?
|
| Histocompatibility Antigens | 1 | 2019 | 107 | 0.150 |
Why?
|
| Metabolomics | 1 | 2024 | 702 | 0.150 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2019 | 99 | 0.150 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2019 | 134 | 0.140 |
Why?
|
| Proteomics | 1 | 2024 | 1137 | 0.140 |
Why?
|
| Neuropilin-1 | 1 | 2017 | 7 | 0.130 |
Why?
|
| Neoplasm Metastasis | 1 | 2020 | 674 | 0.130 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2017 | 67 | 0.130 |
Why?
|
| Up-Regulation | 1 | 2020 | 851 | 0.130 |
Why?
|
| Fatty Acids | 1 | 2020 | 446 | 0.130 |
Why?
|
| Disease Progression | 2 | 2020 | 2808 | 0.120 |
Why?
|
| Nuclear Proteins | 1 | 2017 | 718 | 0.090 |
Why?
|
| Female | 8 | 2024 | 75814 | 0.090 |
Why?
|
| Models, Biological | 1 | 2017 | 1810 | 0.080 |
Why?
|
| Humans | 9 | 2024 | 141284 | 0.070 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2020 | 917 | 0.060 |
Why?
|
| Histones | 2 | 2023 | 641 | 0.060 |
Why?
|
| Mice | 5 | 2022 | 17969 | 0.060 |
Why?
|
| Signal Transduction | 1 | 2017 | 5116 | 0.050 |
Why?
|
| Neuropilins | 1 | 2022 | 1 | 0.050 |
Why?
|
| GTPase-Activating Proteins | 1 | 2022 | 85 | 0.050 |
Why?
|
| Cell Adhesion Molecules | 1 | 2022 | 179 | 0.040 |
Why?
|
| Single-Cell Analysis | 1 | 2024 | 341 | 0.040 |
Why?
|
| Animals | 5 | 2022 | 37328 | 0.040 |
Why?
|
| Tumor Microenvironment | 1 | 2024 | 711 | 0.040 |
Why?
|
| Anoikis | 1 | 2020 | 31 | 0.040 |
Why?
|
| Computational Biology | 1 | 2024 | 663 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2020 | 331 | 0.040 |
Why?
|
| Indazoles | 1 | 2019 | 77 | 0.040 |
Why?
|
| Heterografts | 1 | 2019 | 135 | 0.040 |
Why?
|
| Neoplasm Grading | 1 | 2019 | 311 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2022 | 605 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2022 | 738 | 0.040 |
Why?
|
| Transcriptome | 1 | 2024 | 1007 | 0.030 |
Why?
|
| Biomarkers, Tumor | 1 | 2024 | 1250 | 0.030 |
Why?
|
| Zinc Finger Protein Gli2 | 1 | 2017 | 4 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2020 | 627 | 0.030 |
Why?
|
| Piperidines | 1 | 2019 | 217 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2020 | 368 | 0.030 |
Why?
|
| COS Cells | 1 | 2017 | 179 | 0.030 |
Why?
|
| NIH 3T3 Cells | 1 | 2017 | 148 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2019 | 444 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2017 | 305 | 0.030 |
Why?
|
| Amino Acid Motifs | 1 | 2017 | 223 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2017 | 270 | 0.030 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2017 | 150 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2017 | 233 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2019 | 734 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2020 | 1080 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2022 | 1075 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2017 | 403 | 0.030 |
Why?
|
| Protein Transport | 1 | 2017 | 446 | 0.030 |
Why?
|
| Indoles | 1 | 2019 | 472 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2017 | 672 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2022 | 1706 | 0.030 |
Why?
|
| Prognosis | 1 | 2022 | 4080 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 2017 | 696 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 1761 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2017 | 4149 | 0.020 |
Why?
|
| Mutation | 1 | 2017 | 4006 | 0.020 |
Why?
|